Nkarta Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.28

+0.10 (+3.14%)

As of May 16, 2:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +405.2% upside

Low Target $14.06

Average Target $16.57

High Target $23.26

Current Price $3.28

Current
$3.28

Target
$16.57

$14.06 $16.57 avg $23.26

Scenario Analysis

Bear Case

$14.06

328.7%

Low target

Base Case

$16.57

+405.2%

Avg target

Bull Case

$23.26

+609.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.65

-10.1% from high

52-Week Low

$1.63

+101.2% from low

Target vs 52W High

$16.57

+354.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%